Use of insulin glargine during pregnancyPDYHONEN-ALHO, Maritta; RONNEMAA, Tapani; SALTEVO, Juha et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 10, pp 1171-1174, issn 0001-6349, 4 p.Article

Dosing of insulin glargine in the treatment of type 2 diabetesBARNETT, Anthony.Clinical therapeutics. 2007, Vol 29, Num 6, pp 987-999, issn 0149-2918, 13 p.Article

Insulin glargine: a new basal insulin analogueYOUNIS, N; SORAN, H; BOWEN-JONES, D et al.QJM (Oxford. 1994. Print). 2002, Vol 95, Num 11, pp 757-761, issn 1460-2725, 5 p.Article

Early retinopathy progression in four randomized trials comparing insulin glargine and Nph insulinDAVIS, M. D; BECK, R. W; HOME, P. D et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 4, pp 240-243, issn 0947-7349, 4 p.Article

Optimization of basal insulin delivery in Type 1 diabetes : a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargineFAHLEN, M; ELIASSON, B; ODEN, A et al.Diabetic medicine. 2005, Vol 22, Num 4, pp 382-386, issn 0742-3071, 5 p.Article

Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

Early hypoglycaemia after accidental intramuscular injection of insulin glargineKARGES, B; BOEHM, B. O; KARGES, W et al.Diabetic medicine. 2005, Vol 22, Num 10, pp 1444-1445, issn 0742-3071, 2 p.Article

Insulin analogues : Action profiles beyond glycaemic controlECKARDT, Kristin; ECKEL, Jürgen.Archives of physiology and biochemistry. 2008, Vol 114, Num 1, pp 45-53, issn 1381-3455, 9 p.Conference Paper

Insulin glargine in combination with nateglinide in people with type 2 diabetes : a randomized placebo-controlled trialDASHORA, U. K; SIBAL, L; ASHWELL, S. G et al.Diabetic medicine. 2007, Vol 24, Num 4, pp 344-349, issn 0742-3071, 6 p.Article

Biotransformation of insulin glargine after subcutaneous injection in healthy subjectsKUERZEL, G. U; SHUKLA, U; SCHOLTZ, H. E et al.Current medical research and opinion. 2003, Vol 19, Num 1, pp 34-40, issn 0300-7995, 7 p.Article

An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetesSCHIAFFINI, Riccardo; CIAMPALINI, Paolo; SPERA, Sabrina et al.Diabetes/metabolism research and reviews (Print). 2005, Vol 21, Num 4, pp 347-352, issn 1520-7552, 6 p.Article

Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusionSCHOLTZ, H. E; PRETORIUS, S. G; WESSELS, D. H et al.Acta diabetologica (Print). 2003, Vol 40, Num 4, pp 156-162, issn 0940-5429, 7 p.Article

Pas de lien formel entre insulîne glargine et cancerBABAI, Samy; BROCVIELLE, Hélène; LE LOUET, Hervé et al.Médecine (Montrouge). 2009, Vol 5, Num 9, issn 1777-2044, p. 399Article

Prescription of insulin glargine in primary care practices in GermanyRATHMANN, W; HAASTERT, B; RIEBEL, P et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 4, pp 252-256, issn 0947-7349, 5 p.Article

Fasting and insulin glargine in individuals with type 1 diabetesMUCHA, Gregory T; MERKEL, Stacia; THOMAS, William et al.Diabetes care. 2004, Vol 27, Num 5, pp 1209-1210, issn 0149-5992, 2 p.Article

Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS studyRACCAH, D; HAAK, T. J; HUET, D et al.Diabetes & metabolism. 2012, Vol 38, Num 6, pp 507-514, issn 1262-3636, 8 p.Article

Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitusJANKA, Hans U; PLEWE, Gerd; BUSCH, Klaus et al.Journal of the American Geriatrics Society. 2007, Vol 55, Num 2, pp 182-188, issn 0002-8614, 7 p.Article

Insulin glargine and receptor-mediated signalling : clinical implications in treating type 2 diabetesLE ROITH, Derek.Diabetes/metabolism research and reviews (Print). 2007, Vol 23, Num 8, pp 593-599, issn 1520-7552, 7 p.Article

Treatment with insulin glargine does not suppress serum IGF-1SLAWIK, M; SCHORIES, M; BUSSE GRAWITZ, A et al.Diabetic medicine. 2006, Vol 23, Num 7, pp 814-817, issn 0742-3071, 4 p.Article

Injection of acidic or neutral insulin and pain : A single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitusKARGES, Beate; MUCHE, Rainer; RIEGGER, Ines et al.Clinical therapeutics. 2006, Vol 28, Num 12, pp 2094-2101, issn 0149-2918, 8 p.Article

A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lisproJOHANSSON, U. B; WREDLING, R; ADAMSON, U et al.Diabetes & metabolism. 2007, Vol 33, Num 6, pp 469-471, issn 1262-3636, 3 p.Article

Contributions of Basal and Prandial Hyperglycemia to Total Hyperglycemia in Older and Younger Adults with Type 2 Diabetes MellitusMUNSHI, Medha N; PANDYA, Naushira; UMPIERREZ, Guillermo E et al.Journal of the American Geriatrics Society. 2013, Vol 61, Num 4, pp 535-541, issn 0002-8614, 7 p.Article

Basal-prandial insulin therapy : Scientific concept review and applicationLEAHY, Jack L.The American journal of the medical sciences. 2006, Vol 332, Num 1, pp 24-31, issn 0002-9629, 8 p.Article

Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic medicine. 2003, Vol 20, Num 7, pp 545-551, issn 0742-3071, 7 p.Article

Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glarginePING WU; CHENG JI; MINGLI WANG et al.Annales d'endocrinologie. 2013, Vol 74, Num 1, pp 56-58, issn 0003-4266, 3 p.Article